RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production.
Researchers developed DoriVac, a DNA origami-based vaccine platform that precisely arranges antigens and adjuvants to enhance ...
A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...
Next generation influenza vaccines that provide broader and longer-lasting protection than existing seasonal vaccines, could ...
Read more about Future pandemics may be fought faster with mRNA and advanced vaccine platforms on Devdiscourse ...
FDA advisers recommend fall flu shot changes to include the new subclade K H3N2 variant for the 2026-27 season, improving ...
Wyss Institute's DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce ...
Judge Murphy held that wholesale removal of 17 ACIP experts and installation of largely non-expert replacements failed FACA ...
Kevin Ma, PhD, discusses new data showing 2024–2025 COVID-19 vaccines reduced hospitalization and severe outcomes. In this Q&A, lead study author Kevin Ma, PhD, an epidemic intelligence service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results